Rxi Pharmaceuticals Corp (NASDAQ:RXII)

During the Trading Day
1.50 +0.27 / +21.95%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.55 +0.05 / +3.33%
 
Volume: 8.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

--

--
Revenue and IncomeNet Revenues97.0K399.0K----
 
 
 
Depreciation And Amortization147.0K99.0K----
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.9M21.2M----
 
 
 
Research And Development10.5M17.7M----
 
 
 
Total Operating Expenses13.1M21.3M----
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-20.9M----
 
 
 
Extraordinary Credit13.0K0.00----
 
 
Interest Expense On Debt30.0K0.00----
 
 
Other Expenses125.0K0.00----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.9M-20.9M----
 
 
 
Preferred Dividend-12.8M-8.6M----
 
 
 
Net Income-12.9M-20.9M----
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.6M10.3M----
 
 
 
Shares To Calculate EPS Diluted4.6M10.3M----
 
 
 
 
Earnings Per ShareEPS-$5.70-$2.88----
 
 
 
EPS Diluted-$5.70-$2.88----
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account